slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 74,611-74,640
Pages 3,225
Rows per page 30
Component
74,611-74,640 of 96,741
326
The slide uses direct quotes from former territory managers to substantiate allegations of fraudulent marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses a Q&A transcript format to expose potentially fraudulent sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses highlighted text to emphasize key allegations regarding pressure and compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
332
The slide uses a Q&A format to present whistleblower testimony regarding unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
334
The slide uses direct quotes from former territory managers to establish the 'unusual' nature of the compensation plan.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses direct quotes from two different ex-Harmony territory managers to build a case of systemic non-compliance and arbitrary quota setting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
336
The slide uses a Q&A transcript format to highlight the 'weird' nature of the compensation process at Harmony.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
337
The slide uses a Q&A transcript format to highlight alleged unethical practices and lack of transparency in sales compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
338
Includes direct Q&A transcript excerpts highlighting the alleged lack of transparency and short-term focus.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight the discrepancy between industry standards and Harmony's practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
341
The slide uses highlighted text to emphasize key phrases from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses a Q&A format to build a case for regulatory or ethical misconduct.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
343
The slide uses a combination of narrative summary and Q&A transcript to build a case of corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
344
The slide uses a Q&A format to expose a scheme where management facilitates off-label marketing.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
345
The slide uses a Q&A format to document testimony regarding corporate fraud and off-label promotion.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
346
The slide uses a Q&A transcript format to substantiate claims of unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
347
The slide uses a Q&A transcript format to highlight the interviewee's cynical view on the prevalence of the disease.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
348
The slide uses a Q&A format to expose a potential business practice of incentivizing off-label drug prescriptions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
350
The slide uses highlighted text to emphasize key admissions of fraudulent behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
351
The slide uses a Q&A transcript format to highlight potential violations of the Stark Law.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
353
The slide uses a Q&A format to highlight systemic issues and potential regulatory non-compliance regarding speaker programs and off-label prescriptions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
354
The slide uses highlighted text to emphasize key allegations of off-label promotion and retaliation against employees.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
356
The slide uses Q&A format to present expert testimony regarding potential regulatory violations and mismanagement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
357
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
358
The slide uses direct quotes from former employees to validate the thesis of market saturation and internal company struggles.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
359
The slide uses a Q&A format to validate the thesis that high-volume prescribers quickly exhaust their patient pool and face insurance hurdles, contradicting potential growth narratives.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
360
Includes verbatim interview transcripts highlighting the 'crash' after initial launch spikes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
362
The slide uses direct quotes from ex-managers to highlight a shift in company culture towards aggressive performance management.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
363
The slide uses a Q&A format to validate the thesis of a slowing business.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
364
The slide uses direct quotes from a KOL to contradict the company's narrative of market growth.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit